Jan Mrosek

Treatment delay and tumor size in patients with oral cancer during the first year of the <scp>COVID</scp>‐19 pandemic

Karl Metzger, Jan Mrosek, Sven Zittel et al. · Head & Neck · 2021 · 47 citations · Full text

Clinical outcome and prognostic factors in recurrent oral squamous cell carcinoma after primary surgical treatment: a retrospective study

Sven Zittel, Julius Moratin, Dominik Horn et al. · Clinical Oral Investigations · 2021 · 37 citations · Full text

Full-Thickness Tumor Resection of Oral Cancer Involving the Facial Skin—Microsurgical Reconstruction of Extensive Defects after Radical Treatment of Advanced Squamous Cell Carcinoma

Julius Moratin, Jan Mrosek, Dominik Horn et al. · Cancers · 2021 · 24 citations · Full text

Surgical Oncology, Surgery, Dermatology +16

Levosimendan, a new therapeutic approach to prevent delayed cerebral vasospasm after subarachnoid hemorrhage?

Juergen Konczalla, Stefan Wanderer, Jan Mrosek et al. · Acta Neurochirurgica · 2016 · 21 citations · Full text

Subarachnoid Hemorrhage, Neurophysiology, Intracranial Pressure +10

Crosstalk Between the Angiotensin and Endothelin-System in the Cerebrovasculature

Juergen Konczalla, Stefan Wanderer, Jan Mrosek et al. · Current Neurovascular Research · 2013 · 15 citations